Index
1 Heart Failure Drugs Market Overview
1.1 Product Overview and Scope of Heart Failure Drugs
1.2 Heart Failure Drugs Segment by Type
1.2.1 Global Heart Failure Drugs Market Value Comparison by Type (2024-2030)
1.2.2 ACEI
1.2.3 Angiotensin II Receptor Blockers
1.2.4 ARNIs
1.2.5 Beta Blockers
1.2.6 Aldosterone Antagonists
1.2.7 Diuretics
1.3 Heart Failure Drugs Segment by Application
1.3.1 Global Heart Failure Drugs Market Value by Application: (2024-2030)
1.3.2 Reduced Ejection Fraction
1.3.3 Preserved Ejection Fraction
1.4 Global Heart Failure Drugs Market Size Estimates and Forecasts
1.4.1 Global Heart Failure Drugs Revenue 2019-2030
1.4.2 Global Heart Failure Drugs Sales 2019-2030
1.4.3 Global Heart Failure Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Heart Failure Drugs Market Competition by Manufacturers
2.1 Global Heart Failure Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Heart Failure Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Heart Failure Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Heart Failure Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Heart Failure Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Heart Failure Drugs, Product Type & Application
2.7 Heart Failure Drugs Market Competitive Situation and Trends
2.7.1 Heart Failure Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Heart Failure Drugs Players Market Share by Revenue
2.7.3 Global Heart Failure Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Heart Failure Drugs Retrospective Market Scenario by Region
3.1 Global Heart Failure Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Heart Failure Drugs Global Heart Failure Drugs Sales by Region: 2019-2030
3.2.1 Global Heart Failure Drugs Sales by Region: 2019-2024
3.2.2 Global Heart Failure Drugs Sales by Region: 2025-2030
3.3 Global Heart Failure Drugs Global Heart Failure Drugs Revenue by Region: 2019-2030
3.3.1 Global Heart Failure Drugs Revenue by Region: 2019-2024
3.3.2 Global Heart Failure Drugs Revenue by Region: 2025-2030
3.4 North America Heart Failure Drugs Market Facts & Figures by Country
3.4.1 North America Heart Failure Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Heart Failure Drugs Sales by Country (2019-2030)
3.4.3 North America Heart Failure Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Heart Failure Drugs Market Facts & Figures by Country
3.5.1 Europe Heart Failure Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Heart Failure Drugs Sales by Country (2019-2030)
3.5.3 Europe Heart Failure Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Heart Failure Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Heart Failure Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Heart Failure Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Heart Failure Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Heart Failure Drugs Market Facts & Figures by Country
3.7.1 Latin America Heart Failure Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Heart Failure Drugs Sales by Country (2019-2030)
3.7.3 Latin America Heart Failure Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Heart Failure Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Heart Failure Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Heart Failure Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Heart Failure Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Heart Failure Drugs Sales by Type (2019-2030)
4.1.1 Global Heart Failure Drugs Sales by Type (2019-2024)
4.1.2 Global Heart Failure Drugs Sales by Type (2025-2030)
4.1.3 Global Heart Failure Drugs Sales Market Share by Type (2019-2030)
4.2 Global Heart Failure Drugs Revenue by Type (2019-2030)
4.2.1 Global Heart Failure Drugs Revenue by Type (2019-2024)
4.2.2 Global Heart Failure Drugs Revenue by Type (2025-2030)
4.2.3 Global Heart Failure Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Heart Failure Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Heart Failure Drugs Sales by Application (2019-2030)
5.1.1 Global Heart Failure Drugs Sales by Application (2019-2024)
5.1.2 Global Heart Failure Drugs Sales by Application (2025-2030)
5.1.3 Global Heart Failure Drugs Sales Market Share by Application (2019-2030)
5.2 Global Heart Failure Drugs Revenue by Application (2019-2030)
5.2.1 Global Heart Failure Drugs Revenue by Application (2019-2024)
5.2.2 Global Heart Failure Drugs Revenue by Application (2025-2030)
5.2.3 Global Heart Failure Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Heart Failure Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Heart Failure Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Heart Failure Drugs Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Heart Failure Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Heart Failure Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Corporation Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Heart Failure Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 AstraZeneca Heart Failure Drugs Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Hikma
6.4.1 Hikma Corporation Information
6.4.2 Hikma Description and Business Overview
6.4.3 Hikma Heart Failure Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hikma Heart Failure Drugs Product Portfolio
6.4.5 Hikma Recent Developments/Updates
6.5 Teva
6.5.1 Teva Corporation Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva Heart Failure Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Teva Heart Failure Drugs Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 Cipla
6.6.1 Cipla Corporation Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Heart Failure Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Cipla Heart Failure Drugs Product Portfolio
6.6.5 Cipla Recent Developments/Updates
6.7 Merck & Co.
6.6.1 Merck & Co. Corporation Information
6.6.2 Merck & Co. Description and Business Overview
6.6.3 Merck & Co. Heart Failure Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck & Co. Heart Failure Drugs Product Portfolio
6.7.5 Merck & Co. Recent Developments/Updates
6.8 Amgen
6.8.1 Amgen Corporation Information
6.8.2 Amgen Description and Business Overview
6.8.3 Amgen Heart Failure Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Amgen Heart Failure Drugs Product Portfolio
6.8.5 Amgen Recent Developments/Updates
6.9 Roche
6.9.1 Roche Corporation Information
6.9.2 Roche Description and Business Overview
6.9.3 Roche Heart Failure Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Roche Heart Failure Drugs Product Portfolio
6.9.5 Roche Recent Developments/Updates
6.10 Sun Pharma
6.10.1 Sun Pharma Corporation Information
6.10.2 Sun Pharma Description and Business Overview
6.10.3 Sun Pharma Heart Failure Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Sun Pharma Heart Failure Drugs Product Portfolio
6.10.5 Sun Pharma Recent Developments/Updates
6.11 Mylan
6.11.1 Mylan Corporation Information
6.11.2 Mylan Heart Failure Drugs Description and Business Overview
6.11.3 Mylan Heart Failure Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Mylan Heart Failure Drugs Product Portfolio
6.11.5 Mylan Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Heart Failure Drugs Industry Chain Analysis
7.2 Heart Failure Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Heart Failure Drugs Production Mode & Process
7.4 Heart Failure Drugs Sales and Marketing
7.4.1 Heart Failure Drugs Sales Channels
7.4.2 Heart Failure Drugs Distributors
7.5 Heart Failure Drugs Customers
8 Heart Failure Drugs Market Dynamics
8.1 Heart Failure Drugs Industry Trends
8.2 Heart Failure Drugs Market Drivers
8.3 Heart Failure Drugs Market Challenges
8.4 Heart Failure Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer